Month: February 2019

SEONGNAM, South Korea, Feb. 11, 2019 /PRNewswire/ — Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company presented the preclinical and the…

SHENYANG, China and BOSTON, Feb. 11, 2019 /PRNewswire/ — 3SBio Inc. (“3SBio”) (HKEX:1530) and Verseau Therapeutics, Inc. (“Verseau”) announced today a partnership agreement focused on the development and commercialization of…

SUZHOU, China, Feb. 8, 2019 /PRNewswire/ — CStone Pharmaceutical (“CStone”) and IMPACT Therapeutics, Inc. (“IMPACT”) today jointly announced that an Investigational New Drug (IND) filing has been accepted by the…

Medical imaging’s critical role in supporting high impact patient care approaches centred on outcomes SANTA CLARA, California, Feb. 7, 2019 /PRNewswire/ — The triple aim objectives in healthcare provision and…

BANGKOK, Thailand, Feb. 7, 2019 /PRNewswire/ — Under its Thailand 4.0 vision, Thailand plans to leverage on its reputation and excellence in medical services and medical devices and strengthen its…

-New partner ecosystem enables companies to enhance and expand drug and medical device development initiatives PHILADELPHIA, Feb. 7, 2019 /PRNewswire/ — Clarivate Analytics, a global leader in providing trusted insights…

SINGAPORE, Feb. 7, 2019 /PRNewswire/ — In commemoration of the very first Extracorporeal Shockwave Lithotripsy (ESWL) procedure performed on 7 February 1980, Dornier MedTech (Dornier) has announced a global competition…

DARMSTADT, Germany, Feb. 6, 2019 /PRNewswire/ — Not intended for US, Canada or UK-based media Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline Merck investing $70…

SHENZHEN, China, Feb. 6, 2019 /PRNewswire/ — Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has announced the official launch of its brand new…